Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPersimmon Regulatory News (PSN)

Share Price Information for Persimmon (PSN)

Share Price is delayed by 15 minutes
Get Live Data
1,078.50    26.00 (2.47%)
Bid:
1,071.00
Ask:
1,072.00
Spread: 1.00 (0.093%)
Market Cap: £3.46b
PSN Live PriceLast checked at - London Stock Exchange

Intraday Persimmon Share Chart

Director/PDMR Shareholding

31 Mar 2025 15:14

RNS Number : 9789C
Persimmon PLC
31 March 2025
 

 

31 March 2025

Persimmon Plc (the "Company")

 

Director/PDMR Shareholding

 

Persimmon Plc announces that on 28 March 2025 awards were granted to Dean Finch, Group Chief Executive, and Andrew Duxbury, Chief Financial Officer, over 59,854 and 31,122 shares respectively, under the Persimmon Plc 2020 Deferred Bonus Plan. The awards are for the deferred element of the Executive Directors' annual bonus and will ordinarily vest after a three-year period ending on the announcement of the Group's 2027 results.

 

In the case of Andrew Duxbury, this includes the deferred element of his bonus for the buy-out period prior to his joining Persimmon. Further details are included in the Persimmon Directors' Remuneration Report for the year ended 31 December 2024.

 

The below notification, made in accordance with the requirements of the UK Market Abuse Regulation, gives further details:

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

Dean Finch

2

 

Reason for the notification

 

a)

 

Position/status

 

Group Chief Executive

b)

 

Initial notification /Amendment

 

Initial notification

3

 

Details of the issuer, UK emission allowance market participant, auction platform or auctioneer

 

a)

 

Name

 

Persimmon Plc

b)

 

LEI

 

213800XI72Y57UWN6F31

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

Transaction 1

a)

 

Description of the financial instrument, type of instrument

Ordinary shares of 10p each

Identification code

GB0006825383

b)

 

Nature of the transaction

 

 

Grant of award made under the 2020 Deferred Bonus Plan for the deferred element of Dean Finch's 2025 annual bonus, which will ordinarily vest after a 3-year period ending on the announcement of the Group's 2027 results.

 

c)

 

Price(s) and volume(s)

Price(s)

Volume(s)

Nil

59,854

 

 

d)

 

Aggregated information

- Aggregated volume

N/A Single transaction

- Price

N/A Single transaction

e)

 

Date of the transaction

 

28 March 2025

f)

Place of the transaction

Outside a trading venue

 

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

Andrew Duxbury

2

 

Reason for the notification

 

a)

 

Position/status

 

Chief Financial Officer

b)

 

Initial notification /Amendment

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Persimmon Plc

b)

 

LEI

 

213800XI72Y57UWN6F31

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

Transaction 1

a)

 

Description of the financial instrument, type of instrument

Ordinary shares of 10p each

Identification code

GB0006825383

b)

 

Nature of the transaction

 

 

Grant of award made under the 2020 Deferred Bonus Plan for the deferred element of Andrew Duxbury's 2025 annual bonus, which will ordinarily vest after a 3-year period ending on the announcement of the Group's 2027 results.

 

c)

 

Price(s) and volume(s)

Price(s)

Volume(s)

Nil

31,122

 

 

d)

 

Aggregated information

- Aggregated volume

N/A Single transaction

- Price

N/A Single transaction

e)

 

Date of the transaction

 

28 March 2025

f)

Place of the transaction

Outside a trading venue

 

 

Tracy Davison

Company Secretary

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHEALDFDFDSEFA
Date   Source Headline
17th May 202211:30 amRNSHolding(s) in Company
3rd May 20222:49 pmRNSTotal Voting Rights
27th Apr 20224:43 pmRNSResult of AGM
27th Apr 20227:00 amRNSTrading Statement
26th Apr 20229:55 amRNSHolding(s) in Company
20th Apr 20224:34 pmRNSHolding(s) in Company
5th Apr 202211:04 amRNSPersimmon signs UK Government’s Developer Pledge
1st Apr 202211:18 amRNSTotal Voting Rights
28th Mar 20224:30 pmRNSDirector/PDMR Shareholding
23rd Mar 202212:30 pmRNSAnnual Report 2021 and Notice of AGM 2022
22nd Mar 20225:18 pmRNSDirector/PDMR Shareholding
9th Mar 20221:12 pmRNSDirector/PDMR Shareholding
2nd Mar 20227:00 amRNSFull Year Results
1st Mar 20223:34 pmRNSTotal Voting Rights
1st Feb 20221:58 pmRNSTotal Voting Rights
19th Jan 20223:37 pmRNSDirector/PDMR Shareholding
13th Jan 20227:04 amRNSAppointment of Chief Financial Officer
13th Jan 20227:00 amRNSTrading Statement
4th Jan 20224:50 pmRNSTotal Voting Rights
2nd Dec 202110:10 amRNSBlock listing Interim Review
1st Dec 202110:43 amRNSTotal Voting Rights
30th Nov 20212:33 pmRNSDirector/PDMR Shareholding
9th Nov 20217:00 amRNSTrading Statement
18th Aug 20217:00 amRNSHalf Year Results
27th Jul 20217:44 amRNSDirector Declaration
26th Jul 202111:02 amRNSFinance Director Succession
8th Jul 20217:00 amRNSTrading Update
1st Jul 20212:45 pmRNSTotal Voting Rights
25th Jun 20212:27 pmRNSAppointment of Independent Non-Executive Director
23rd Jun 20217:05 amRNSVoluntary Agreement With CMA
1st Jun 20214:24 pmRNSTotal Voting Rights
1st Jun 20212:15 pmRNSBlock listing Interim Review
21st May 20217:12 amRNSDirector Declaration
4th May 20211:09 pmRNSTotal Voting Rights
28th Apr 202112:33 pmRNSResult of AGM
28th Apr 20217:00 amRNSTrading Update
1st Apr 20213:52 pmRNSTotal Voting Rights
26th Mar 20211:20 pmRNSAnnual Report 2020 and Notice of AGM 2021
23rd Mar 20213:27 pmRNSDirector/PDMR Shareholding
23rd Mar 202111:09 amRNSDirector Declaration
22nd Mar 202111:01 amRNSDirector/PDMR Shareholding
8th Mar 20211:39 pmRNSDirector/PDMR Shareholding
3rd Mar 20217:00 amRNSFinal Results
1st Mar 20213:52 pmRNSTotal Voting Rights
10th Feb 20217:00 amRNSPersimmon Acts to Address Legacy Cladding Issues
1st Feb 20212:19 pmRNSTotal Voting Rights
13th Jan 20217:00 amRNSTrading Statement
4th Jan 20213:10 pmRNSTotal Voting Rights
17th Dec 20201:12 pmRNSAppointment of Independent Non-Executive Director
15th Dec 20207:00 amRNSComposition of Remuneration Committee

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.